Showing 261 - 280 results of 1,028 for search '"Разработка и регистрация лекарственных средств"', query time: 0.05s Refine Results
  1. 261
    Investigation of the Chemical Composition and Dopaminergic Activity of the Vitex Agnus-castus Fruits

    Investigation of the Chemical Composition and Dopaminergic Activity of the Vitex Agnus-castus Fruits by G. V. Adamov, E. S. Melnikov, I. A. Lupanova, A. I. Radimich, O. L. Saybel

    Published 2020-08-01
    “…Разработка и регистрация лекарственных средств…”
    Get full text
    Article
    Save to List
    Saved in:
  2. 262
    DEVELOPMENT AND VALIDATION THE METHOD OF QUANTITATIVE DETERMINATION OF ETORICOXIB IN SOLID PHARMACEUTICAL FORMS BY HPLC

    DEVELOPMENT AND VALIDATION THE METHOD OF QUANTITATIVE DETERMINATION OF ETORICOXIB IN SOLID PHARMACEUTICAL FORMS BY HPLC by T. L. Batalova, O. A. Ostapyuk, K. R. Saveleva, T. Y. Andreevicheva, L. V. Persanova, S. V. Polyakov, V. N. Shestakov

    Published 2019-01-01
    “…Разработка и регистрация лекарственных средств…”
    Get full text
    Article
    Save to List
    Saved in:
  3. 263
    Application of Luminescent Microscopy in Analysis of Anatomic-diagnostic Signs of Fruits of Sea Buckthorn

    Application of Luminescent Microscopy in Analysis of Anatomic-diagnostic Signs of Fruits of Sea Buckthorn by O. V. Trineeva, A. A. Gudkova, M. A. Rudaya

    Published 2020-02-01
    “…Разработка и регистрация лекарственных средств…”
    Get full text
    Article
    Save to List
    Saved in:
  4. 264
    TOPICAL ISSUES OF TRAINING OF GMP INSPECTORS

    TOPICAL ISSUES OF TRAINING OF GMP INSPECTORS by V. N. Shestakov, Yu. V. Podpruzhnikov

    Published 2019-01-01
    “…Разработка и регистрация лекарственных средств…”
    Get full text
    Article
    Save to List
    Saved in:
  5. 265
    EMBININ IS A PERSPECTIVE CARDIOTONIC MEAN FOR NATURAL ORIGIN

    EMBININ IS A PERSPECTIVE CARDIOTONIC MEAN FOR NATURAL ORIGIN by D. Yu. Ivkin, V. G. Luzhanin, A. A. Karpov, S. M. Minasyan, Ya. I. Poleshchenko, A. E. Mamedov, M. N. Povydysh, V. V. Poroykov, I. A. Narkevich

    Published 2019-01-01
    “…Разработка и регистрация лекарственных средств…”
    Get full text
    Article
    Save to List
    Saved in:
  6. 266
    Validation of Chromatographic Methods: Checking the Peak Purity and the Specificity of Methods with Diode Array Detectors (Review)

    Validation of Chromatographic Methods: Checking the Peak Purity and the Specificity of Methods with Diode Array Detectors (Review) by N. A. Epshtein

    Published 2020-08-01
    “…Разработка и регистрация лекарственных средств…”
    Get full text
    Article
    Save to List
    Saved in:
  7. 267
    Double Proteolysis for N- and O-glycan Analysis of Fc-fusion Protein Etanercept

    Double Proteolysis for N- and O-glycan Analysis of Fc-fusion Protein Etanercept by V. G. Varzieva, N. V. Mesonzhnik, A. О. Belushenko, N. L. Bochkareva, S. А. Appolonova

    Published 2023-02-01
    “…Разработка и регистрация лекарственных средств…”
    Get full text
    Article
    Save to List
    Saved in:
  8. 268
    Development and Validation of a Method for Determining Deferasirox in Human Blood Plasma by HPLC-UV

    Development and Validation of a Method for Determining Deferasirox in Human Blood Plasma by HPLC-UV by P. A. Karpova, T. N. Komarov, O. A. Archakova, D. S. Shchelgacheva, A. V. Suvorova, N. S. Bagaeva, P. K. Karnakova, I. E. Shohin

    Published 2022-05-01
    “…Разработка и регистрация лекарственных средств…”
    Get full text
    Article
    Save to List
    Saved in:
  9. 269
    DEVELOPMENT OF TECHNOLOGY AND METHODS OF CONTROL OF BIFUNCTIONAL OINTMENT

    DEVELOPMENT OF TECHNOLOGY AND METHODS OF CONTROL OF BIFUNCTIONAL OINTMENT by K. R. Saveleva, T. Y. Andreevicheva, L. V. Persanova, O. A. Ostapyuk, S. V. Polyakov, V. N. Shestakov

    Published 2019-01-01
    “…Разработка и регистрация лекарственных средств…”
    Get full text
    Article
    Save to List
    Saved in:
  10. 270
    The Influence of Deuterium on the Properties of Pharmaceutical Substances (Review)

    The Influence of Deuterium on the Properties of Pharmaceutical Substances (Review) by A. V. Syroeshkin, T. E. Elizarova, T. V. Pleteneva, E. V. Uspenskaya, O. V. Levitskaya, I. A. Zlatskiy, T. V. Maksimova

    Published 2020-05-01
    “…Разработка и регистрация лекарственных средств…”
    Get full text
    Article
    Save to List
    Saved in:
  11. 271
    Chemical and Toxicological Analysis of Antiretroviral Drugs

    Chemical and Toxicological Analysis of Antiretroviral Drugs by T. N. Komarov, M. V. Belova, D. D. Stolyarova, I. E. Shohin, D. S. Bogdanova, O. A. Miskiv, Yu. V. Medvedev, I. M. Korenskaya

    Published 2019-11-01
    “…Разработка и регистрация лекарственных средств…”
    Get full text
    Article
    Save to List
    Saved in:
  12. 272
    ANTIDIABETIC ACTIVITY OF GUANIDINIUM SALT 2-AMINOPHENYLACETATE

    ANTIDIABETIC ACTIVITY OF GUANIDINIUM SALT 2-AMINOPHENYLACETATE by E. V. Ponomarenko

    Published 2019-01-01
    “…Разработка и регистрация лекарственных средств…”
    Get full text
    Article
    Save to List
    Saved in:
  13. 273
    Development of Ocular Inserts Based on Import Substituted Poloxamer Emuxol 268

    Development of Ocular Inserts Based on Import Substituted Poloxamer Emuxol 268 by E. O. Bakhrushina, A. R. Turaeva, D. R. Zhalyalova, D. A. Klimov, N. B. Demina, I. I. Krasnuk

    Published 2024-03-01
    “…Разработка и регистрация лекарственных средств…”
    Get full text
    Article
    Save to List
    Saved in:
  14. 274
    Development of Effervescent Granules with Solid Dispersion of Furazolidone

    Development of Effervescent Granules with Solid Dispersion of Furazolidone by A. O. Elagina, A. V. Beliatskaya, I. I. Krasnyuk (Jr.), I. I. Krasnyuk, O. I. Stepanova, A. N. Vorob'yov, T. V. Fateeva

    Published 2022-02-01
    “…Разработка и регистрация лекарственных средств…”
    Get full text
    Article
    Save to List
    Saved in:
  15. 275
    Documentation of Pharmaceutical Development. Part 2. Quality System Documents

    Documentation of Pharmaceutical Development. Part 2. Quality System Documents by I. E. Smekhova, L. V. Shigarova, I. A. Narkevich, E. V. Flisyuk, V. D. Meteleva

    Published 2021-05-01
    “…Разработка и регистрация лекарственных средств…”
    Get full text
    Article
    Save to List
    Saved in:
  16. 276
    "Pharmtech & Ingredients –2024"

    "Pharmtech & Ingredients –2024" by article Editorial

    Published 2025-03-01
    “…Разработка и регистрация лекарственных средств…”
    Get full text
    Article
    Save to List
    Saved in:
  17. 277
    Dependence of Antimicrobial Effects of Guanidine-containing Pectin Derivatives from Some Structural Characteristics

    Dependence of Antimicrobial Effects of Guanidine-containing Pectin Derivatives from Some Structural Characteristics by O. R. Akhmedov, S. A. Shomurotov, A. S. Turaev, A. V. Sidarenka

    Published 2022-05-01
    “…Разработка и регистрация лекарственных средств…”
    Get full text
    Article
    Save to List
    Saved in:
  18. 278
    CHLORIDE-2-[(1Z)-1-(3,5-DIPHENYL-1,3,4-THYADIAZOLE-2(3H)-ILIDEN)METHYL]-3,5-DIPHENYL-1,3,4-THYADIAZOLE-3 AS A PROMISING COMPOUND FOR THE DEVELOPMENT OF NEW DRUGS

    CHLORIDE-2-[(1Z)-1-(3,5-DIPHENYL-1,3,4-THYADIAZOLE-2(3H)-ILIDEN)METHYL]-3,5-DIPHENYL-1,3,4-THYADIAZOLE-3 AS A PROMISING COMPOUND FOR THE DEVELOPMENT OF NEW DRUGS by A. S. Koshevenko, V. N. Yuskovets, I. P. Yakovlev, E. P. Ananyeva, T. L. Semakova

    Published 2019-01-01
    “…Разработка и регистрация лекарственных средств…”
    Get full text
    Article
    Save to List
    Saved in:
  19. 279
    Identification and quantitative determination of arbutin in the herb of Orthilia secunda

    Identification and quantitative determination of arbutin in the herb of Orthilia secunda by A. V. Lezina, I. I. Terninko, M. V. Krysko

    Published 2021-12-01
    “…Разработка и регистрация лекарственных средств…”
    Get full text
    Article
    Save to List
    Saved in:
  20. 280
    Development and Validation of the HPLC Method for Quantification of the Innovative Drug DD217, Factor Xa Inhibitor, in Rat Plasma for a Pharmacokinetic Study

    Development and Validation of the HPLC Method for Quantification of the Innovative Drug DD217, Factor Xa Inhibitor, in Rat Plasma for a Pharmacokinetic Study by N. S. Dubovik, D. F. Guranda, G. V. Ramenskaya, D. G. Tovbin, D. N. Tarasov, A. Yu. Savchenko, V. S. Arnautov

    Published 2022-05-01
    “…Разработка и регистрация лекарственных средств…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: